Wells Fargo & Company Lowers Globus Medical (NYSE:GMED) Price Target to $93.00
Globus Medical (NYSE:GMED – Get Free Report) had its price objective lowered by investment analysts at Wells Fargo & Company from $95.00 to $93.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical device company’s stock. Wells Fargo & Company‘s target price would indicate a potential […]
Globus Medical (NYSE:GMED – Get Free Report) had its price objective lowered by investment analysts at Wells Fargo & Company from $95.00 to $93.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical device company’s stock. Wells Fargo & Company‘s target price would indicate a potential […]
